Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.31 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.31 |
| ▸ | PER2 | O15055 | 1/20 | 0.31 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.31 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25870820 | 0.91 | CA1 (0.34) | PER2CRY1CRY2CA1CA2 | |
| SCHEMBL25870826 | 0.87 | PER2 (0.31) | PER2CRY1CRY2 | |
| SCHEMBL25870788 | 0.86 | CA1 (0.34) | MAOBPER2CRY1CRY2CA1 | |
| SCHEMBL25870819 | 0.82 | CA1 (0.34) | CA1CA2CYP19A1 | |
| SCHEMBL25870811 | 0.81 | CA1 (0.31) | CA1CA2 | |
| SCHEMBL25870794 | 0.80 | PER2 (0.34) | MAOBPER2CRY1CRY2MEN1 | |
| SCHEMBL25870782 | 0.78 | MAPT (0.36) | MAOBMEN1PKMKMT2A | |
| SCHEMBL17765710 | 0.77 | SIGMAR1 (0.31) | — | |
| SCHEMBL25870827 | 0.77 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL18913110 | 0.76 | KMT2A (0.37) | MAOBKCNN4KCNA5PER2CRY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11711930-B2 | — | — | 2023-07-25 | — | — | US | disclosed |